BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mei PJ, Bai J, Miao FA, Li ZL, Chen C, Zheng JN, Fan YC. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma. Invest New Drugs 2019;37:646-57. [PMID: 30328556 DOI: 10.1007/s10637-018-0667-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Mukerjee N, Maitra S, Roy S, Modak S, Hasan MM, Chakraborty B, Ghosh A, Ghosh A, Kamal MA, Dey A, Ashraf GM, Malik S, Rahman MH, Alghamdi BS, Abuzenadah AM, Alexiou A. Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme. Metab Brain Dis 2023;38:61-8. [PMID: 36149588 DOI: 10.1007/s11011-022-01082-6] [Reference Citation Analysis]
2 夏 敏. The Research Progress of XRCC1 in Tumor. ACM 2023;13:3104-3110. [DOI: 10.12677/acm.2023.133441] [Reference Citation Analysis]
3 Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway. Int J Biol Sci 2021;17:2380-98. [PMID: 34326682 DOI: 10.7150/ijbs.55453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Liu Y, Wang Y, Yuan W, Dong F, Zhen F, Liu J, Yang L, Qu X, Yao R. Reelin promotes oligodendrocyte precursors migration via the Wnt/β-catenin signaling pathway. Neurol Res 2021;43:543-52. [PMID: 33616025 DOI: 10.1080/01616412.2021.1888604] [Reference Citation Analysis]
5 Pan W, Jiang P, Zhao J, Shi H, Zhang P, Yang X, Biazik J, Hu M, Hua H, Ge X, Huang XF, Yu Y. β-Glucan from Lentinula edodes prevents cognitive impairments in high-fat diet-induced obese mice: involvement of colon-brain axis. J Transl Med 2021;19:54. [PMID: 33541370 DOI: 10.1186/s12967-021-02724-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
6 Zhang X, Wang J, Wang Y, Liu G, Li H, Yu J, Wu R, Liang J, Yu R, Liu X. MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways. Front Oncol 2020;10:608082. [PMID: 33520717 DOI: 10.3389/fonc.2020.608082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Yao R, Xie Y, Sun X, Zhang M, Zhou J, Liu L, Gao J, Xu K. Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma. Drug Des Devel Ther 2020;14:3983-93. [PMID: 33061303 DOI: 10.2147/DDDT.S264077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Liu G, Lu Y, Li L, Jiang T, Chu S, Hou P, Bai J, Chen M. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma. Invest New Drugs 2020;38:1730-42. [PMID: 32533288 DOI: 10.1007/s10637-020-00961-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liu X, Yue C, Shi L, Liu G, Cao Q, Shan Q, Wang Y, Chen X, Li H, Wang J, Gao S, Niu M, Yu R. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. J Cell Mol Med 2020;24:7550-62. [PMID: 32452133 DOI: 10.1111/jcmm.15383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
10 Yang X, Zheng M, Hao S, Shi H, Lin D, Chen X, Becvarovski A, Pan W, Zhang P, Hu M, Huang XF, Zheng K, Yu Y. Curdlan Prevents the Cognitive Deficits Induced by a High-Fat Diet in Mice via the Gut-Brain Axis. Front Neurosci 2020;14:384. [PMID: 32477045 DOI: 10.3389/fnins.2020.00384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
11 Shan Q, Li S, Cao Q, Yue C, Niu M, Chen X, Shi L, Li H, Gao S, Liang J, Yu R, Liu X. Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway. Korean J Physiol Pharmacol 2020;24:193-201. [PMID: 32395070 DOI: 10.4196/kjpp.2020.24.3.193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Wu Z, Miao X, Zhang Y, Li D, Zou Q, Yuan Y, Liu R, Yang Z. XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer. Front Mol Biosci 2020;7:70. [PMID: 32426369 DOI: 10.3389/fmolb.2020.00070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu X, Tu Y, Wang Y, Zhou D, Chong Y, Shi L, Liu G, Zhang X, Wu S, Li H, Gao S, Niu M, Yu R. Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway. Cancer Cell Int 2020;20:97. [PMID: 32256206 DOI: 10.1186/s12935-020-01186-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 Zhang Z, Li X, Xiong F, Ren Z, Han Y. Hsa_circ_0012563 promotes migration and invasion of esophageal squamous cell carcinoma by regulating XRCC1/EMT pathway. J Clin Lab Anal 2020;34:e23308. [PMID: 32185826 DOI: 10.1002/jcla.23308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
15 Mei J, Wang H, Wang R, Pan J, Liu C, Xu J. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma. Biomed Res Int 2020;2020:5751939. [PMID: 32258128 DOI: 10.1155/2020/5751939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]